Global Gene Synthesis Market

Gene Synthesis Market Size, Share, Growth Analysis, By Method(Solid-phase Synthesis, Chip-based Synthesis, and PCR-based Enzyme Synthesis), By Services(Antibody DNA Synthesis, Viral DNA Synthesis, and Others), By Application(Gene & Cell Therapy Development, Vaccine Development, and Disease Diagnosis), By End-use(Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35H2240 | Region: Global | Published Date: February, 2024
Pages: 219 | Tables: 117 | Figures: 77

Gene Synthesis Market Competitive Landscape

Key market participants are pursuing a number of strategic initiatives, including collaborations, partnerships, & geographical expansions in favorable regions. Companies are launching new items to diversify their product portfolios in the market. ProteoGenix, for example, introduced the XtenCHO Transient CHO Expression System in March 2022.

This product makes recombinant protein manufacturing easier, which speeds up early-stage drug screening. Similarly, Integrated DNA Technology, Inc. announced the release of Alt-R HDR Donor Blocks in February 2022, allowing researchers to change the Homology-directed Repair (HDR) genome in order to produce cures.

Top Player’s Company Profiles

  • Eurofins Scientific SE
  • ATUM (formerly DNA2.0)
  • Integrated DNA Technologies, Inc.
  • OriGene Technologies, Inc.
  • Bioneer Corporation
  • GeneArt (a division of Life Technologies)
  • Bio Basic Inc.
  • GENEWIZ LLC
  • BioCat GmbH
  • Eurogentec S.A.
  • Biomatik Corporation
  • Creative Biogene
  • LC Sciences
  • Gene Universal Inc.
  • Blue Heron Biotech LLC
  • Genewell Co., Ltd.
  • Quintara Biosciences Inc.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Gene Synthesis Market size was valued at USD 1.76 Billion in 2022 and is poised to grow from USD 2.04 Billion in 2023 to USD 6.75 Billion by 2031, at a CAGR of 16.10 % during the forecast period (2024-2031).

Key market participants are pursuing a number of strategic initiatives, including collaborations, partnerships, & geographical expansions in favorable regions. Companies are launching new items to diversify their product portfolios in the market. ProteoGenix, for example, introduced the XtenCHO Transient CHO Expression System in March 2022. 'Thermo Fisher Scientific Inc.', 'GenScript Biotech Corporation', 'Twist Bioscience Corporation', 'Eurofins Scientific SE', 'ATUM (formerly DNA2.0)', 'Integrated DNA Technologies, Inc.', 'OriGene Technologies, Inc.', 'Bioneer Corporation', 'GeneArt (a division of Life Technologies)', 'Bio Basic Inc.', 'GENEWIZ LLC', 'BioCat GmbH', 'Eurogentec S.A.', 'Biomatik Corporation', 'Creative Biogene', 'LC Sciences', 'Gene Universal Inc.', 'Blue Heron Biotech LLC', 'Genewell Co., Ltd.', 'Quintara Biosciences Inc.'

Gene synthesis plays a crucial role in various fields of research and development, including molecular biology, genetic engineering, drug discovery, and synthetic biology. It enables scientists to study gene function, create genetically modified organisms, develop novel therapeutic agents, and engineer new biological systems. The expanding applications of gene synthesis in research and development activities drive market growth.

Increasing Demand for Gene Editing and Gene Therapy: The field of gene editing, particularly with technologies like CRISPR-Cas9, has gained significant attention in recent years. Gene synthesis plays a crucial role in providing custom DNA constructs for gene editing experiments and gene therapy applications. The growing interest in gene editing and gene therapy is driving the demand for gene synthesis services.

North America held the highest revenue in 2022. This can be attributed to the presence of many important market participants offering gene synthesis services, as well as the increased interest of large biotechnology and pharmaceutical businesses in gene and cell technologies therapy development, the region's expanding field of synthetic biology, and growing interest in gene production in the molecular biology arena.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

DNA Synthesis Market
Buy Now GET FREE SAMPLE
Gene Editing Market
Buy Now GET FREE SAMPLE
Oligonucleotide Synthesis Market
Buy Now GET FREE SAMPLE
Synthetic Biology Market
Buy Now GET FREE SAMPLE
Gene Therapy Market
Buy Now GET FREE SAMPLE
Gene Amplification Technologies Market
Buy Now GET FREE SAMPLE
Genome Editing Market
Buy Now GET FREE SAMPLE
Genetically Modified Seeds Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Gene Synthesis Market

Report ID: SQMIG35H2240

$5,300
BUY NOW GET FREE SAMPLE